Lab
Meritus Medical Laboratory LLC
Meritus Medical Laboratory LLC was paid $12.14M by Medicaid between Jan 2018 and Dec 2024, across 184 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 34% of everything it billed.
33Billing provider infoMERITUS MEDICAL LABORATORY LLC
HAGERSTOWN, MD 21742
HAGERSTOWN, MD 21742
33aNPI1679518971assigned 06/19/2006
33bProvider typeClinical Medical Laboratory
28Total paid$12.14M
24GClaims733,085
24DCodes billed184
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Maryland
Rank by total paid#3 of 93
Median peer was paid$430K
This provider vs. median28×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official REPAC, JOSHUA controls 17+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 12,314 | $152K | |
| 2019 | 9,476 | $123K | |
| 2020 | 132,349 | $2.32M | |
| 2021 | 154,317 | $3.84M | |
| 2022 | 146,846 | $2.51M | |
| 2023 | 152,078 | $1.71M | |
| 2024incomplete | 125,705 | $1.48M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 34% | 46,043 | 38,881 | $4.08M |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 4.7% | 9,065 | 8,131 | $568K |
| 80061 | Lipid panel | 3.7% | 41,719 | 37,388 | $450K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 3.6% | 1,250 | 1,186 | $442K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 3.6% | 20,282 | 18,019 | $440K |
| 80053 | Comprehensive metabolic panel | 3.6% | 50,435 | 45,075 | $439K |
| 84443 | Thyroid stimulating hormone (TSH) | 3.4% | 30,637 | 28,131 | $413K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.7% | 52,677 | 46,174 | $333K |
| 83036 | Hemoglobin; glycosylated (A1C) | 2.3% | 35,786 | 32,184 | $279K |
| 36415 | Collection of venous blood by venipuncture | 1.6% | 90,418 | 75,984 | $191K |
| 0225U | 1.5% | 531 | 500 | $186K | |
| 82607 | 1.5% | 16,209 | 14,359 | $182K |
172 more codes
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.4% | 2,443 | $170K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 1.1% | 5,858 | $138K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 1.1% | 6,565 | $133K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.0% | 2,669 | $125K |
| 87481 | <1% | 2,776 | $120K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 2,999 | $117K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 3,714 | $116K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 9,795 | $113K |
| 84439 | <1% | 13,561 | $100K | |
| 87536 | <1% | 1,473 | $98K | |
| 82728 | <1% | 7,751 | $85K | |
| 80074 | <1% | 2,263 | $83K | |
| 86780 | <1% | 7,318 | $82K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 2,814 | $79K |
| 87081 | <1% | 13,454 | $79K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 11,176 | $77K |
| 84466 | <1% | 7,454 | $77K | |
| 84702 | <1% | 5,602 | $72K | |
| 87660 | <1% | 3,689 | $66K | |
| 87480 | <1% | 3,692 | $66K | |
| 87510 | <1% | 3,693 | $65K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 8,924 | $64K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,593 | $63K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 2,021 | $61K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,017 | $61K |
| 86480 | <1% | 1,169 | $59K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 687 | $54K |
| 87522 | Neg quan hep c or qual rna | <1% | 1,400 | $52K |
| 88342 | <1% | 1,027 | $52K | |
| 86003 | <1% | 1,064 | $52K | |
| 80050 | General health panel | <1% | 7,620 | $48K |
| 84153 | <1% | 3,366 | $45K | |
| 86618 | <1% | 2,198 | $45K | |
| 83655 | <1% | 4,197 | $44K | |
| 83540 | <1% | 8,271 | $43K | |
| 86803 | <1% | 3,677 | $43K | |
| 84403 | <1% | 2,077 | $42K | |
| 87902 | <1% | 196 | $42K | |
| 85027 | <1% | 7,475 | $42K | |
| 82746 | <1% | 3,676 | $39K | |
| 83970 | <1% | 1,318 | $39K | |
| 82570 | <1% | 7,979 | $36K | |
| 84481 | <1% | 2,568 | $35K | |
| 87186 | <1% | 4,287 | $33K | |
| 86360 | <1% | 776 | $32K | |
| 87634 | <1% | 560 | $31K | |
| 86850 | <1% | 4,444 | $31K | |
| 82043 | <1% | 5,968 | $29K | |
| 86038 | <1% | 2,793 | $29K | |
| 87340 | <1% | 3,306 | $28K | |
| 86762 | <1% | 2,274 | $28K | |
| 86376 | <1% | 2,284 | $28K | |
| 86355 | <1% | 790 | $26K | |
| 86359 | <1% | 788 | $26K | |
| 80076 | <1% | 3,704 | $25K | |
| 81001 | <1% | 8,739 | $23K | |
| 83001 | <1% | 1,301 | $22K | |
| 83516 | <1% | 1,690 | $22K | |
| 84402 | <1% | 1,100 | $21K | |
| 84146 | <1% | 1,209 | $20K | |
| 84425 | <1% | 1,283 | $19K | |
| 85610 | <1% | 6,072 | $19K | |
| 86140 | <1% | 4,424 | $19K | |
| 86706 | <1% | 2,152 | $19K | |
| 83735 | <1% | 3,384 | $18K | |
| 82784 | <1% | 1,480 | $16K | |
| 87147 | <1% | 2,765 | $15K | |
| 86696 | <1% | 865 | $14K | |
| 85730 | <1% | 2,926 | $14K | |
| 82670 | <1% | 536 | $13K | |
| 83525 | <1% | 1,399 | $13K | |
| 87070 | <1% | 1,675 | $13K | |
| 81003 | <1% | 6,664 | $13K | |
| 83002 | <1% | 761 | $12K | |
| 85652 | <1% | 5,291 | $12K | |
| 80069 | <1% | 1,558 | $11K | |
| 86769 | <1% | 294 | $11K | |
| 83690 | <1% | 1,668 | $10K | |
| 82248 | <1% | 2,423 | $10K | |
| 86900 | <1% | 4,018 | $10K | |
| 86901 | <1% | 4,022 | $10K | |
| 86695 | <1% | 865 | $10K | |
| 80164 | <1% | 955 | $9K | |
| 86431 | <1% | 1,991 | $9K | |
| 87077 | <1% | 1,277 | $9K | |
| 87506 | <1% | 190 | $9K | |
| 84154 | <1% | 631 | $9K | |
| 84480 | <1% | 768 | $9K | |
| 82950 | <1% | 2,082 | $9K | |
| 82652 | <1% | 316 | $8K | |
| 84550 | <1% | 2,139 | $8K | |
| 87641 | <1% | 271 | $8K | |
| 82247 | <1% | 1,855 | $7K | |
| 84100 | <1% | 1,850 | $7K | |
| 80306 | <1% | 479 | $7K | |
| 87205 | <1% | 1,803 | $7K | |
| 87428 | <1% | 100 | $7K | |
| 84156 | <1% | 2,094 | $7K | |
| 82550 | <1% | 1,254 | $6K | |
| 85014 | <1% | 2,720 | $5K | |
| 85018 | <1% | 2,711 | $5K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 175 | $5K |
| 83520 | <1% | 415 | $5K | |
| 82105 | <1% | 446 | $5K | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | <1% | 14 | $5K |
| 84630 | <1% | 603 | $5K | |
| 84460 | <1% | 1,184 | $5K | |
| 82172 | <1% | 370 | $4K | |
| 82977 | <1% | 700 | $4K | |
| 86200 | <1% | 379 | $4K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 93 | $4K |
| 88142 | <1% | 200 | $4K | |
| 87420 | <1% | 354 | $3K | |
| 82947 | <1% | 1,035 | $3K | |
| 83615 | <1% | 671 | $3K | |
| 83010 | <1% | 316 | $3K | |
| 83883 | <1% | 269 | $3K | |
| 80178 | <1% | 548 | $3K | |
| 82150 | <1% | 514 | $3K | |
| 86812 | <1% | 112 | $2K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 51 | $2K |
| 86704 | <1% | 221 | $2K | |
| 86160 | <1% | 139 | $2K | |
| 82565 | <1% | 502 | $2K | |
| 84030 | <1% | 412 | $2K | |
| 84165 | <1% | 196 | $2K | |
| 82180 | <1% | 295 | $2K | |
| 84207 | <1% | 101 | $2K | |
| 87338 | <1% | 129 | $2K | |
| 88112 | <1% | 63 | $2K | |
| 82533 | <1% | 118 | $2K | |
| 82951 | <1% | 134 | $2K | |
| 83021 | <1% | 80 | $1K | |
| 85379 | <1% | 143 | $1K | |
| 86787 | <1% | 84 | $1K | |
| 84144 | <1% | 48 | $907.70 | |
| 81015 | <1% | 355 | $844.37 | |
| 86146 | <1% | 12 | $812.56 | |
| 84450 | <1% | 201 | $794.75 | |
| 86592 | <1% | 195 | $686.85 | |
| 83880 | <1% | 25 | $666.20 | |
| 88341 | <1% | 13 | $646.25 | |
| 87075 | <1% | 71 | $640.59 | |
| 86665 | <1% | 27 | $579.65 | |
| 86147 | <1% | 12 | $550.03 | |
| 86317 | <1% | 34 | $547.52 | |
| 86308 | <1% | 117 | $533.12 | |
| 82952 | <1% | 135 | $478.66 | |
| 87177 | <1% | 66 | $468.11 | |
| 84134 | <1% | 37 | $451.94 | |
| 84255 | <1% | 39 | $451.08 | |
| 87493 | <1% | 15 | $447.85 | |
| 87329 | <1% | 42 | $400.18 | |
| 86255 | <1% | 43 | $386.36 | |
| 88304 | <1% | 14 | $380.59 | |
| 86664 | <1% | 27 | $338.16 | |
| 86617 | <1% | 12 | $336.14 | |
| 86800 | <1% | 27 | $320.94 | |
| 82627 | <1% | 15 | $244.54 | |
| 84681 | <1% | 15 | $189.03 | |
| 83090 | <1% | 12 | $183.82 | |
| 86735 | <1% | 14 | $166.53 | |
| 82140 | <1% | 13 | $158.02 | |
| 85041 | <1% | 67 | $151.62 | |
| 85613 | <1% | 12 | $136.39 | |
| 84520 | <1% | 36 | $120.66 | |
| 85045 | <1% | 34 | $106.04 | |
| 85651 | <1% | 18 | $54.10 | |
| 84436 | <1% | 15 | $53.92 | |
| 36416 | <1% | 1,787 | $15.00 | |
| 86920 | 0% | 13 | $0.00 | |
| INVCD | 0% | 46 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialREPAC, JOSHUA (CFO)
| Provider | Location | Paid |
|---|---|---|
| Medical Practices of Antietam, LLC | Hagerstown, MD | $20.56M |
| Brook Lane Behavioral Services, INC. | Frederick, MD | $5.59M |
| Meritus Urgent Care, LLC | Hagerstown, MD | $4.93M |
| Meritus Medical Center INC | Hagerstown, MD | $3.41M |
| Brook Lane Behavioral Services, INC. | Hagerstown, MD | $3.12M |
| Meritus Medical Center INC | Hagerstown, MD | $1.47M |
| Meritus Enterprises,inc. | Hagerstown, MD | $1.28M |
| Meritus Medical Center INC | Hagerstown, MD | $1.18M |
| Meritus Medical Center INC | Hagerstown, MD | $968K |
| Meritus Medical Center INC | Hagerstown, MD | $828K |
| Meritus Medical Center INC | Hagerstown, MD | $517K |
| Meritus Medical Center INC | Hagerstown, MD | $60K |
| Meritus Medical Center INC | Hagerstown, MD | $49K |
| Meritus Medical Center INC | Hagerstown, MD | $17K |
| Meritus Medical Center INC | Hagerstown, MD | $2K |
| Meritus Medical Center, INC. | Hagerstown, MD | $796.87 |
| Meritus Urgent Care LLC | Hagerstown, MD | $92.10 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.